How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

27,019 results for

Skin Conditions of Pregnancy

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Skin Conditions of Pregnancy

Skin Conditions of Pregnancy Skin Conditions of Pregnancy Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Skin Conditions of Pregnancy (...) Skin Conditions of Pregnancy Aka: Skin Conditions of Pregnancy , Pregnancy Related Rash , Dermatitis in Pregnancy , Dermatoses of Pregnancy II. Causes: Pregnancy Specific See (e.g. ) Pruritic of pregnancy III. Causes: Pregnancy-Related Pruritic Conditions See Common Prurigo of Pregnancy Uncommon or Pruritic of Pregnancy IV. Causes: Exacerbated by Pregnancy Nail changes (e.g. , brittle nails, grooves) Telangiectasias s (regress after pregnancy) V. References Images: Related links to external sites

2018 FP Notebook

2. Vitamin D Postpartum Concentrations: Relationship with Nutritional Condition and Morbidities during Pregnancy (PubMed)

Vitamin D Postpartum Concentrations: Relationship with Nutritional Condition and Morbidities during Pregnancy To evaluate postpartum vitamin D deficiency/insufficiency and to relate it to pregestational BMI, gestational weight gain, and sociodemographic variables.This is a cross-sectional study with 225 full-term pregnant women. Data collected are as follows: maternal health, socioeconomic status, pregestational body mass index (BMI), and gestational weight gain. Laboratory evaluation included (...) vitamin D [25(OH)D], calcium, phosphorus, magnesium, and alkaline phosphatase.The mean age of women was 25.6±6.6 years. Dark skin color, low education, and work in the urban region were predominant. Regular sun exposure, photoprotection, and vitamin D supplementation were reported by 144 (64.0%), 44 (19.6%), and 5 (2.2%) women, respectively. The mean plasma concentrations of 25(OH)D were 26.0±6.8 ng/mL. Levels compatible with deficiency (<20 ng/mL) and insufficiency (20-30 ng/mL) were observed in 43

Full Text available with Trip Pro

2018 Journal of pregnancy

3. A Practical Guide About Tattooing in Patients with Chronic Skin Disorders and Other Medical Conditions. (PubMed)

A Practical Guide About Tattooing in Patients with Chronic Skin Disorders and Other Medical Conditions. With tattoos becoming increasingly mainstream, dermatologists are more and more often consulted by patients who are considering getting an ornamental, cosmetic, or even a medical tattoo, and who subsequently ask for advice. This includes not only patients with chronic skin diseases such as psoriasis or atopic dermatitis but also patients with other medical conditions. This review first (...) result. Our aim was to provide dermatologists with the current knowledge they need to help their patients make adequate and informed choices on skin art, focusing specifically on considerations in patients with chronic skin conditions. Finally, other aspects regarding some general systemic conditions and concomitant diseases that the patient could present are also addressed. In particular, the risks of tattooing in patients with diabetes, coagulation disorders, heart conditions, immunosuppressive

2017 American journal of clinical dermatology

4. Skin temperature and reproductive condition in wild female chimpanzees (PubMed)

Skin temperature and reproductive condition in wild female chimpanzees Infrared thermal imaging has emerged as a valuable tool in veterinary medicine, in particular for evaluating reproductive processes. Here, we explored differences in skin temperature of twenty female chimpanzees in Budongo Forest, Uganda, four of which were pregnant during data collection. Based on previous literature in other mammals, we predicted increased skin temperature of maximally swollen reproductive organs of non (...) but no significant change between the fertile and non-fertile phases. Despite their different reproductive state, pregnant females had very similar skin temperature patterns compared to non-pregnant females, suggesting little potential for males to use skin temperature to recognise pregnancies, especially during maximal swelling, when ovulation is most likely to occur in non-pregnant females. We discuss this pattern in light of the concealment hypothesis, i.e., that female chimpanzees have evolved physiological

Full Text available with Trip Pro

2017 PeerJ

5. Improvement of skin condition in striae distensae: development, characterization and clinical efficacy of a cosmetic product containing Punica granatum seed oil and Croton lechleri resin extract (PubMed)

Improvement of skin condition in striae distensae: development, characterization and clinical efficacy of a cosmetic product containing Punica granatum seed oil and Croton lechleri resin extract Striae distensae are a frequent skin condition associated with pregnancy, weight change or lack of skin elasticity. The aim of this research was to obtain a topical product containing herbal active ingredients with documented antioxidant and anti-inflammatory activity (Punica granatum seed oil (...) and Croton lechleri resin extract) and demonstrate its positive effect on prevention and treatment of striae distensae. First, the cream base formulation was optimized through experimental design. Secondly, the cream containing the two active ingredients was investigated in an interventional nonrandomized clinical trial. The clinical outcome was assessed through biophysical parameters and ultrasonographic evaluation. The state of the skin was evaluated by biophysical measurements and ultrasonography

Full Text available with Trip Pro

2017 Drug design, development and therapy

6. Adalimumab (Hyrimoz) - Juvenile Rheumatoid Arthritis, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Crohn Disease, Papulosquamous Skin Diseases, Hidradenitis Suppurativa, Ankylosing Spondylitis, Uveitis

Adalimumab (Hyrimoz) - Juvenile Rheumatoid Arthritis, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Crohn Disease, Papulosquamous Skin Diseases, Hidradenitis Suppurativa, Ankylosing Spondylitis, Uveitis 1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how (...) response to or are intolerant to conventional therapy, or in whom conventional therapy is inappropriate. 4.2 Posology and method of administration Hyrimoz treatment should be initiated and supervised by specialist physicians experienced in the diagnosis and treatment of conditions for which Hyrimoz is indicated. Ophthalmologists are advised to consult with an appropriate specialist before initiation of treatment with Hyrimoz (see section 4.4). Patients treated with Hyrimoz should be given the patient

2018 European Medicines Agency - EPARs

7. Overview of pregnancy complications

cholestasis of pregnancy (ICP) is a pruritic condition caused by impaired bile flow allowing bile salts to be deposited in the skin and the placenta. Usually presents in the third trimester with pruritus, which is worse at night, starts on the soles of feet and hands, and spares the face. Some women may present with jaundice and significant liver dysfunction, coagulopathy from vitamin K deficiency (rarely), abnormal fetal heart rate, premature labour, or intrauterine fetal demise. Risk factors include (...) Overview of pregnancy complications Overview of pregnancy complications - Summary of relevant conditions | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Overview of pregnancy complications Last reviewed: February 2019 Last updated: September 2018 Introduction Complications in pregnancy can result from conditions that are specifically linked to the pregnant state as well as conditions that commonly arise or occur incidentally in women who are pregnant

2018 BMJ Best Practice

8. Overview of pregnancy complications

cholestasis of pregnancy (ICP) is a pruritic condition caused by impaired bile flow allowing bile salts to be deposited in the skin and the placenta. Usually presents in the third trimester with pruritus, which is worse at night, starts on the soles of feet and hands, and spares the face. Some women may present with jaundice and significant liver dysfunction, coagulopathy from vitamin K deficiency (rarely), abnormal fetal heart rate, premature labour, or intrauterine fetal demise. Risk factors include (...) Overview of pregnancy complications Overview of pregnancy complications - Summary of relevant conditions | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Overview of pregnancy complications Last reviewed: February 2019 Last updated: September 2018 Introduction Complications in pregnancy can result from conditions that are specifically linked to the pregnant state as well as conditions that commonly arise or occur incidentally in women who are pregnant

2018 BMJ Best Practice

9. Does vitamin B3 (nicotinamide) prevent non-melanoma skin cancer?

Australia, recruited through two tertiary teaching hospitals, who had at least two histologically confirmed non-melanoma skin cancers in the previous 5 years. Important exclusions: immunosuppression, pregnancy or breastfeeding, cancer (metastatic cancer, invasive melanoma, or internal malignancy) in the previous 5 years, a genetic skin-cancer syndrome, large areas of confluent skin cancer (where individual lesions could not be counted), and had used several therapies (nicotinamide containing supplements (...) conducted study of a common condition in Australia. That nicotinamide may have a beneficial effect on non-melanoma skin cancers is well established in prior bench and phase 2 trials (see Stat Facts), and thus, a plausible hypothesis. However, there is imprecision in the estimate in the primary outcome. The confidence interval of the relative difference between groups ranged over an order of magnitude from 4% to 38%. We need to consider questions about external validity [2]: Is my patient so different

2018 Morsels of Evidence

10. Does vitamin B3 (nicotinamide) prevent non-melanoma skin cancer?

Australia, recruited through two tertiary teaching hospitals, who had at least two histologically confirmed non-melanoma skin cancers in the previous 5 years. Important exclusions: immunosuppression, pregnancy or breastfeeding, cancer (metastatic cancer, invasive melanoma, or internal malignancy) in the previous 5 years, a genetic skin-cancer syndrome, large areas of confluent skin cancer (where individual lesions could not be counted), and had used several therapies (nicotinamide containing supplements (...) conducted study of a common condition in Australia. That nicotinamide may have a beneficial effect on non-melanoma skin cancers is well established in prior bench and phase 2 trials (see Stat Facts), and thus, a plausible hypothesis. However, there is imprecision in the estimate in the primary outcome. The confidence interval of the relative difference between groups ranged over an order of magnitude from 4% to 38%. We need to consider questions about external validity [2]: Is my patient so different

2018 Morsels of Evidence

11. Does vitamin B3 (nicotinamide) prevent non-melanoma skin cancer?

adults from Sydney Australia, recruited through two tertiary teaching hospitals, who had at least two histologically confirmed non-melanoma skin cancers in the previous 5 years. Important exclusions: immunosuppression, pregnancy or breastfeeding, cancer (metastatic cancer, invasive melanoma, or internal malignancy) in the previous 5 years, a genetic skin-cancer syndrome, large areas of confluent skin cancer (where individual lesions could not be counted), and had used several therapies (nicotinamide (...) This was a well conducted study of a common condition in Australia. That nicotinamide may have a beneficial effect on non-melanoma skin cancers is well established in prior bench and phase 2 trials (see Stat Facts), and thus, a plausible hypothesis. However, there is imprecision in the estimate in the primary outcome. The confidence interval of the relative difference between groups ranged over an order of magnitude from 4% to 38%. We need to consider questions about external validity [2]: Is my patient so

2018 Morsels of Evidence

12. Treating Opioid Use Disorder During Pregnancy: Guideline Supplement

Treating Opioid Use Disorder During Pregnancy: Guideline Supplement 1 Guideline Supplement Treatment of Opioid Use Disorder During2 THIS IS A BLANK PAGE3 A Guideline for the Clinical Management of Opioid Use Disorder—Pregnancy Supplement The BC Centre on Substance Use (BCCSU) is a provincially networked platform mandated to develop, imple- ment, and evaluate evidence-based approaches to substance use and addiction. The BCCSU’s focus is on three strategic areas including research and evaluation (...) Health and Addictions, & Perinatal Services BC. A Guideline for the Clinical Management of Opioid Use Disorder—Pregnancy Supplement. Published June 1, 2018. Available at: http://www.bccsu.ca/care-guid- ance-publications/4 AUTHOr S AND CONTr IBUTOr S Guideline Development Committee Ronald Abrahams (Committee Co-chair), MD, CCFP , FCFP , M.S.C.; Clinical Professor, Dept. Family Practice, UBC; Medical Director, Perinatal Addictions, BCWH Andrea Ryan (Committee Co-chair), MD, CCFP , Dip. ISAM; Clinical

2018 British Columbia Perinatal Health Program

13. Syphilis in pregnancy

conditional decisions to testing · When there is optional (rather than recommended) testing at birth, there is a greater chance that women who are ‘at risk’ are not identified as such and are not appropriately tested Referral pathways · Establish local referral pathways, that are culturally appropriate, to support access to care for women with syphilis in pregnancy · At the time of presentation, individualise the most appropriate pathway to the woman’s circumstances (e.g. from emergency department (...) is an obligate human parasite Transmission · Direct contact with infectious lesions of the mucous membranes or abraded skin 29,30 : o Almost always as sexually transmitted infection o Contact with moist mucocutaneous lesions of an infected baby · Vertical transmission (transplacental passage) during pregnancy: o Treponema pallidum readily crosses the placenta o Can occur as early as 9–10 weeks gestation o Can occur at any stage of disease, including during incubation, although risk is greatest in infectious

2019 Queensland Health

14. Care of Women with Obesity in Pregnancy

Royal College of Obstetricians and Gynaecologists151. Bell J, Bell S, Vahratian A, Awonuga AO. Abdominal surgical incisions and perioperative morbidity among morbidly obese women undergoing cesarean delivery. Eur J Obstet Gynecol Reprod Biol 2011;154:16–9. 152. Brocato BE, Thorpe EM Jr, Gomez LM, Wan JY, Mari G. The effect of cesarean delivery skin incision approach in morbidly obese women on the rate of classical hysterotomy. J Pregnancy 2013;2013:890296. 153. Edwards RK, Kumar R, Zhi D, Szychowski (...) Care of Women with Obesity in Pregnancy Care of Women with Obesity in Pregnancy Green-top Guideline No. 72 November 2018 Please cite this paper as: Denison FC, Aedla NR, Keag O, Hor K, Reynolds RM, Milne A, Diamond A, on behalf of the Royal College of Obstetricians and Gynaecologists. Care of Women with Obesity in Pregnancy. Green-top Guideline No. 72. BJOG 2018DOI: 10.1111/1471-0528.15386 RCOG Green-top Guidelines Care of Women with Obesity in Pregnancy FC Denison, NR Aedla, O Keag, K Hor, RM

2018 Royal College of Obstetricians and Gynaecologists

15. Immune Modulating Therapies in Pregnancy and Lactation

by those organizations. The American College of Obstetricians and Gynecologists has neither solicited nor accepted any commercial involvement in the development of the content of this published product. Immune Modulating Therapies in Pregnancy and Lactation ABSTRACT: Because autoimmune conditions occur more often among women of childbearing age, continuation of these medications during pregnancy is often considered to optimize disease management in the woman and pregnancy outcomes, without placing (...) a variety of immunomodulating drugs, defined in this document as agents that inhibit or modulate the immune response. Because autoimmune conditions occur more often among women of childbearing age ( ), continuation of these medications during pregnancy is often considered to optimize disease management in the woman and pregnancy outcomes ( ), without placing the fetus at undue risk ( ). Emerging safety and efficacy data regarding the use of these medications during pregnancy and lactation can be used

2019 American College of Obstetricians and Gynecologists

16. Oral retinoid medicines: revised and simplified pregnancy prevention educational materials for healthcare professionals and women

to support the Pregnancy Prevention Programme for the oral retinoid medicines acitretin, alitretinoin, and isotretinoin have been revised and simplified due to a high risk of serious congenital malformations, these medicines must not be used in pregnancy, and any use in women and girls must be within the conditions of a Pregnancy Prevention Programme, which are consistent with those previously in place (see below) Advice for healthcare professionals about neuropsychiatric reactions: advice about (...) favourable. The review recommended that educational materials for patients and healthcare professionals about pregnancy prevention measures should be simplified and made consistent and warnings about neuropsychiatric disorders harmonised across oral retinoid medicines (see ). Review of the effectiveness of pregnancy prevention measures Revised and simplified educational materials Women and girls of childbearing potential taking oral retinoids to treat dermatological conditions must be supported

2019 MHRA Drug Safety Update

17. Bacterial vaginosis in pregnancy and risk of spontaneous preterm delivery

Bacterial vaginosis in pregnancy and risk of spontaneous preterm delivery Bacterial vaginosis, proposal for the Danish guideline meeting 2015 (version 190214) Page 1 Bacterial vaginosis in pregnancy and risk of spontaneous preterm delivery Approved at the obstetrical guideline-meeting January 2015 Danish Society of Obstetrics and Gynecology (DSOG) Update February 2019 The Lancet has now published reference 31b, by Subtil et al. (2018). The 2015 version of the DSOG guideline included (...) The objective of this guideline is to evaluate bacterial vaginosis in pregnancy concerning • Different treatments for prevention of preterm delivery. • Screening of pregnant women with low as well as high risk of sPTD. • Stratification into gestational ages below and above 16 weeks. • Diagnostic methods. Key words Bacterial vaginosis, vaginal pH, pH-glove, vaginal discharge, Nugent score, Amsel score, Gardnerella vaginalis, Mobiluncus species, preterm delivery, preterm birth, GRADE, clindamycin

2019 Nordic Federation of Societies of Obstetrics and Gynecology

18. UK guidelines on the management of iron deficiency in pregnancy

. I have read and accept the Wiley Online Library Terms and Conditions of Use. Shareable Link Use the link below to share a full-text version of this article with your friends and colleagues. Copy URL Share a link Share on ). The prevalence of anaemia in pregnancy remains high. In order to minimise adverse outcomes, including use of blood transfusion, further research is required to define optimal management, as many current recommendations are not supported by high quality evidence. Methods (...) UK guidelines on the management of iron deficiency in pregnancy UK guidelines on the management of iron deficiency in pregnancy - Pavord - - British Journal of Haematology - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term Guideline Free Access UK guidelines on the management of iron deficiency in pregnancy Department of Haematology, Oxford University Hospitals, Oxford, UK Women's Health Research

2019 British Committee for Standards in Haematology

19. Updated measures for pregnancy prevention during retinoid use

retinoids are also used to treat certain forms of cancer. The review confirmed that oral retinoids can harm the unborn child and must not be used during pregnancy. In addition, the oral retinoids acitretin, alitretinoin and isotretinoin, which are used to treat conditions mainly affecting the skin, must be used in accordance with the conditions of a new pregnancy prevention programme by women able to have children. Topical retinoids (those applied to the skin) must also not be used during pregnancy (...) final opinion. The opinion will be sent to the European Commission, which will take a final legally binding decision valid across the EU. Information for patients Retinoid medicines, used mainly to treat conditions affecting the skin such as severe acne, are harmful to the unborn baby if taken during pregnancy. Oral (taken by mouth) retinoids must not be used during pregnancy. In addition, the oral retinoids acitretin, alitretinoin and isotretinoin must not be taken by women able to have children

2018 European Medicines Agency - EPARs

20. Cholestasis of pregnancy

disease with bile acid levels >40 micromol/L or severe pruritus remote from term can be treated effectively with ursodeoxycholic acid. Close fetal surveillance with delivery near term can be expected with premature delivery reserved for those with severe, worsening disease despite treatment. Definition Intrahepatic cholestasis of pregnancy (ICP) is a pruritic condition during pregnancy caused by impaired bile flow allowing bile salts to be deposited in the skin and the placenta. The cause (...) Cholestasis of pregnancy Cholestasis of pregnancy - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Cholestasis of pregnancy Last reviewed: February 2019 Last updated: October 2017 Summary May be associated with an increased risk of adverse pregnancy outcomes, including premature birth, intra-uterine fetal demise, and placental abruption in severe disease. There is an increased risk of respiratory distress syndrome

2017 BMJ Best Practice

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>